Understanding Mounjaro UK: A Guide to Weight Loss and Diabetes
Mounjaro (tirzepatide) has officially launched in the UK, marking a significant milestone in the treatment of type 2 diabetes and chronic weight management . Approved by the MHRA, Mounjaro is a first-of-its-kind "dual agonist" medication. Unlike previous treatments that target a single hormone, Mounjaro mimics two naturally occurring gut hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual action provides a more powerful effect on blood sugar regulation and appetite suppression than single-hormone alternatives. How Mounjaro Works The medication works by activating receptors in the brain and digestive system to communicate fullness and regulate metabolism. GIP Action: Enhances insulin secretion and improves how the body breaks down sugar and fat. GLP-1 Action: Slows gastric emptying, meaning food stays in the stomach longer, which extends the feeling of satiety. Combined Effect: By significantly reducing "food no...